©The Author(s) 2025.
World J Gastroenterol. Oct 7, 2025; 31(37): 107665
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.107665
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.107665
Table 1 Wilson and Jungner criteria for assessing screening eligibility
| Wilson and Jungner criteria | |
| Disease | The condition sought should be an important health problem |
| The natural history of the condition, including development from latent to declared disease, should be adequately understood | |
| There should be a recognizable latent or early symptomatic stage | |
| Diagnosis | There should be a suitable test or examination |
| The test should be acceptable to the population | |
| Case-finding should be a continuing process and not a “once and for all” project | |
| Treatment | There should be an agreed policy on whom to treat as patients |
| There should be an accepted treatment for patients with recognized disease | |
| Setting | Facilities for diagnosis and treatment should be available |
| Cost-effectiveness | The cost of case-finding should be economically balanced in relation to possible expenditure on medical care as a whole |
- Citation: Pustjens J, Brouwer WP, Ayada I, Janssen HLA, van Kleef LA. Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populations. World J Gastroenterol 2025; 31(37): 107665
- URL: https://www.wjgnet.com/1007-9327/full/v31/i37/107665.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i37.107665